UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19-associated coagulopathy and disseminated intravascular coagulation

International journal of hematology, 2021-01, Vol.113 (1), p.45-57

2021

Volltextzugriff (PDF)

Diversity of disseminated intravascular coagulation and selection of appropriate treatments

International journal of hematology, 2021-01, Vol.113 (1), p.10-14

Asakura, Hidesaku

2021

Volltextzugriff (PDF)

Potential of heparin and nafamostat combination therapy for COVID‐19

Journal of thrombosis and haemostasis, 2020-06, Vol.18 (6), p.1521-1522

2020

Volltextzugriff (PDF)

Consideration of Tranexamic Acid Administration to COVID-19 Patients

Physiological reviews, 2020-10, Vol.100 (4), p.1595-1596

2020

Volltextzugriff (PDF)

How We Interpret Thrombosis with Thrombocytopenia Syndrome?

International journal of molecular sciences, 2024-05, Vol.25 (9), p.4956

2024

Volltextzugriff (PDF)

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination

International journal of molecular sciences, 2022-03, Vol.23 (6), p.3338

2022

Volltextzugriff (PDF)

Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1296

2022

Volltextzugriff (PDF)

Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations

International journal of hematology, 2021, Vol.113 (1), p.15-23

2021

Volltextzugriff (PDF)

Vaccine‐induced immune thrombotic thrombocytopenia: Update on diagnosis and management considering different resources: Comment from Yamada et al

Journal of thrombosis and haemostasis, 2022-02, Vol.20 (2), p.540-541

2022

Volltextzugriff (PDF)

Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential

Critical care (London, England), 2019-08, Vol.23 (1), p.280-280, Article 280

2019

Volltextzugriff (PDF)

Etiology and Management of Bleeding during ECMO in a COVID-19 Patient

Journal of Atherosclerosis and Thrombosis, 2021/04/01, Vol.28(4), pp.402-403

2021

Volltextzugriff (PDF)

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC

Journal of intensive care, 2020-09, Vol.8 (1), p.71-71, Article 71

2020

Volltextzugriff (PDF)

Effect of Anticoagulant/Antifibrinolytic Combination Therapy on Enhanced Fibrinolytic-Type Disseminated Intravascular Coagulation in End-of-Life Stage Solid Tumor Patients

Journal of palliative medicine, 2023-02, Vol.26 (2), p.307-311

2023

Volltextzugriff (PDF)

Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation

International journal of infectious diseases, 2021-01, Vol.102, p.529-531

2021

Volltextzugriff (PDF)

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey

Critical care (London, England), 2014-09, Vol.18 (5), p.497-497, Article 497

2014

Volltextzugriff (PDF)

Detailed exploration of pathophysiology involving inflammatory status and bleeding symptoms between lipopolysaccharide- and tissue factor-induced disseminated intravascular coagulation in rats

International journal of hematology, 2021-08, Vol.114 (2), p.172-178

2021

Volltextzugriff (PDF)

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis

Thrombosis journal, 2016-09, Vol.14 (1), p.42-42, Article 42

2016

Volltextzugriff (PDF)

Classifying types of disseminated intravascular coagulation: clinical and animal models

Journal of intensive care, 2014-03, Vol.2 (1), p.20-20, Article 20

Asakura, Hidesaku

2014

Volltextzugriff (PDF)

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity

Critical care (London, England), 2016-09, Vol.20 (1), p.287-287, Article 287

2016

Volltextzugriff (PDF)

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: A prospective multicenter survey

Thrombosis research, 2012-09, Vol.130 (3), p.e129-e133

2012

Volltextzugriff (PDF)

Effect on Plasma Protein S Activity in Patients Receiving the Factor Xa Inhibitors

Journal of Atherosclerosis and Thrombosis, 2022/07/01, Vol.29(7), pp.1059-1068

2022

Volltextzugriff (PDF)

Potential of continuous tPA infusion for multiple-organ failure from lipopolysaccharide-induced disseminated intravascular coagulation in rats

Thrombosis research, 2021-10, Vol.206, p.84-87

2021

Volltextzugriff (PDF)

Adjunctive therapies for early withdrawal from extracorporeal membrane oxygenation

Journal of cardiac surgery, 2020-12, Vol.35 (12), p.3671-3672

2020

Volltextzugriff (PDF)

A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC

Clinical and applied thrombosis/hemostasis, 2018-04, Vol.24 (3), p.439-445

2018

Volltextzugriff (PDF)

Possibility of PMX‐DHP therapy as a principal strategy against cytokine storm in COVID‐19: Insights from reconstructed coagulation data

Journal of clinical apheresis, 2021-10, Vol.36 (5), p.785-786

2021

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(161)
Mit Volltextzugriff
(166)

Publikationsform

Artikel
(231)
Berichte
(4)

Sprache

Englisch
(197)
Japanisch
(126)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(135)
Science & Technology
(135)
Humans
(128)
Hematology
(94)
Male
(82)
Biological And Medical Sciences
(62)
Medical Sciences
(61)
Disseminated Intravascular Coagulation
(58)
Female
(58)
Adult
(49)
Cardiovascular System & Cardiology
(48)
Middle Aged
(44)
Peripheral Vascular Disease
(44)
Aged
(42)
Hematologic And Hematopoietic Diseases
(40)
Disseminated Intravascular Coagulation - Drug Therapy
(26)
Dic
(24)
Platelet Diseases And Coagulopathies
(24)
Animals
(23)
Disseminated Intravascular Coagulation - Etiology
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

COVID-19-associated coagulopathy and disseminated intravascular coagulation

Diversity of disseminated intravascular coagulation and selection of appropriate treatments

Potential of heparin and nafamostat combination therapy for COVID‐19

Consideration of Tranexamic Acid Administration to COVID-19 Patients

How We Interpret Thrombosis with Thrombocytopenia Syndrome?

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination

Therapeutic Strategies for Disseminated Intravascular Coagulation Associated with Aortic Aneurysm

Management of disseminated intravascular coagulation associated with aortic aneurysm and vascular malformations

Vaccine‐induced immune thrombotic thrombocytopenia: Update on diagnosis and management considering different resources: Comment from Yamada et al

Thrombomodulin in disseminated intravascular coagulation and other critical conditions-a multi-faceted anticoagulant protein with therapeutic potential

Etiology and Management of Bleeding during ECMO in a COVID-19 Patient

Perspective on fibrinolytic therapy in COVID-19: the potential of inhalation therapy against suppressed-fibrinolytic-type DIC

Effect of Anticoagulant/Antifibrinolytic Combination Therapy on Enhanced Fibrinolytic-Type Disseminated Intravascular Coagulation in End-of-Life Stage Solid Tumor Patients

Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey

Detailed exploration of pathophysiology involving inflammatory status and bleeding symptoms between lipopolysaccharide- and tissue factor-induced disseminated intravascular coagulation in rats

Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis

Classifying types of disseminated intravascular coagulation: clinical and animal models

Revision of the Japanese Association for Acute Medicine (JAAM) disseminated intravascular coagulation (DIC) diagnostic criteria using antithrombin activity

Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: A prospective multicenter survey

Effect on Plasma Protein S Activity in Patients Receiving the Factor Xa Inhibitors

Potential of continuous tPA infusion for multiple-organ failure from lipopolysaccharide-induced disseminated intravascular coagulation in rats

Adjunctive therapies for early withdrawal from extracorporeal membrane oxygenation

A Proposal of the Modification of Japanese Society on Thrombosis and Hemostasis (JSTH) Disseminated Intravascular Coagulation (DIC) Diagnostic Criteria for Sepsis-Associated DIC

Possibility of PMX‐DHP therapy as a principal strategy against cytokine storm in COVID‐19: Insights from reconstructed coagulation data

Suchergebnisse filtern